Novel biomaterials for cartilage tissue engineering

Current Rheumatology Reviews

Volumn 5, Issue 1, 2009, Pages 51-57

  Vial, Ximena ^a   Andreopoulos, Fotios M ^a,b  

^a University of Miami College of Engineering   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; BIOMATERIAL; GROWTH FACTOR; HYALURONIC ACID; MACROGOL; MOLECULAR SCAFFOLD;

ARTICULAR CARTILAGE; BIODEGRADABILITY; BIOENGINEERING; BIOMIMETICS; CHONDROGENESIS; COMPRESSION; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; MECHANICAL STIMULATION; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; WEIGHT BEARING;

EID: 65949105290     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339709787315366     Document Type: Review

References (73)

1. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002; 295(5557): 1009-14.
2. Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I, Mainil-Varlet P. Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev 2006; 58(2): 300-22.
3. Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007; 59(4-5): 339-59.
4. Bonzani IC, George JH, Stevens MM. Novel materials for bone and cartilage regeneration. Curr Opin Chem Biol 2006; 10(6): 568-75.
5. Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000; 21(5): 431-40.
6. Nehrer S, Domayer S, Dorotka R, Schatz K, Bindreiter U, Kotz R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 2006; 57(1): 3-8.
7. Nehrer S, Breinan HA, Ramappa A, et al. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials 1998; 19(24): 2313-28.
8. Nehrer S, Breinan HA, Ramappa A, et al. Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes. Biomaterials 1997; 18(11): 769-76.
9. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 2006; 18(1): 64-73.
10. Lu L, Zhu X, Valenzuela RG, Currier BL, Yaszemski MJ. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop Relat Res 2001; (391Suppl): S251-70.
11. Swieszkowski W, Tuan BH, Kurzydlowski KJ, Hutmacher DW. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 2007; 24(5): 489-95.
12. Chung C, Burdick JA. Engineering cartilage tissue. Adv Drug Deliv Rev 2008; 60(2): 243-62.
13. Mano JF, Reis RL. Osteochondral defects: present situation and tissue engineering approaches. J Tissue Eng Regen Med 2007; 1(4): 261-73.
14. Dickson G, Buchanan F, Marsh D, Harkin-Jones E, Little U, McCaigue M. Orthopaedic tissue engineering and bone regeneration. Technol Health Care 2007; 15(1): 57-67.
15. Raghunath J, Rollo J, Sales KM, Butler PE, Seifalian AM. Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Biochem 2007; 46(Pt 2): 73-84.
16. Mano JF, Silva GA, Azevedo HS, et al. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 2007; 4(17): 999-1030.
17. Mikos AG, Herring SW, Ochareon P, et al. Engineering complex tissues. Tissue Eng 2006; 12(12): 3307-39.
18. Hsu SH, Chang SH, Yen HJ, Whu SW, Tsai CL, Chen DC. Evaluation of biodegradable polyesters modified by type II collagen and Arg-Gly-Asp as tissue engineering scaffolding materials for cartilage regeneration. Artif Organs 2006; 30(1): 42-55.
19. Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 2007; 6(2): 162-67.
20. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001; 55(2): 141-50.
21. Hennink WE, van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev 2002; 54(1):13-36.
22. Vinatier C, Guicheux J, Daculsi G, Layrolle P, Weiss P. Cartilage and bone tissue engineering using hydrogels. Biomed Mater Eng 2006; 16(4 Suppl): S107-13.
23. Martens PJ, Bryant SJ, Anseth KS. Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering. Biomacromolecules 2003; 4(2): 283-92.
24. Liao E, Yaszemski M, Krebsbach P, Hollister S. Tissue-engineered cartilage constructs using composite hyaluronic acid/collagen I hydrogels and designed poly(propylene fumarate) scaffolds. Tissue Eng 2007; 13(3): 537-50.
25. Lee HJ, Lee JS, Chansakul T, Yu C, Elisseeff JH, Yu SM. Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials 2006; 27(30): 5268-76.
26. Huin-Amargier C, Marchal P, Payan E, Netter P, Dellacherie E. New physically and chemically crosslinked hyaluronate (HA)-based hydrogels for cartilage repair. J Biomed Mater Res A 2006; 76(2): 416-24.
27. Lee WK, Ichi T, Ooya T, Yamamoto T, Katoh M, Yui N. Novel poly(ethylene glycol) scaffolds crosslinked by hydrolyzable polyrotaxane for cartilage tissue engineering. J Biomed Mater Res A 2003; 67(4): 1087-92.
28. Buxton AN, Zhu J, Marchant R, West JL, Yoo JU, Johnstone B. Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells. Tissue Eng 2007; 13(10): 2549-60.
29. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001; 101(7): 1869-79.
30. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 2003; 67(4): 1105-14.
31. Woodfield TB, Malda J, de Wijn J, Peters F, Riesle J, van Blitterswijk CA. Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique. Biomaterials 2004; 25(18): 4149-61.
32. Uematsu K, Hattori K, Ishimoto Y, et al. Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold. Biomaterials 2005; 26(20): 4273-79.
33. Muller FA, Muller L, Hofmann I, Greil P, Wenzel MM, Staudenmaier R. Cellulose-based scaffold materials for cartilage tissue engineering. Biomaterials 2006; 27(21): 3955-63.
34. Sontjens SH, Nettles DL, Carnahan MA, Setton LA, Grinstaff MW. Biodendrimer-based hydrogel scaffolds for cartilage tissue repair. Biomacromolecules 2006; 7(1): 310-16.
35. Bhardwaj T, Pilliar RM, Grynpas MD, Kandel RA. Effect of material geometry on cartilagenous tissue formation in vitro. J Biomed Mater Res 2001; 57(2): 190-99.
36. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004; 25(26): 5735-42.
37. Hile DD, Amirpour ML, Akgerman A, Pishko MV. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2). J Control Release 2000; 66(2-3): 177-85.
38. Sato T, Chen G, Ushida T, et al. Evaluation of PLLA - collagen hybrid sponge as a scaffold for cartilage tissue engineering. Materials Science and Engineering C 2004; 24(3): 365-72.
39. Mahmood TA, Shastri VP, van Blitterswijk CA, Langer R, Riesle J. Tissue engineering of bovine articular cartilage within porous poly(ether ester) copolymer scaffolds with different structures. Tissue Eng 2005; 11(7-8): 1244-53.
40. Kang Y, Yang J, Khan S, Anissian L, Ameer GA. A new biodegradable polyester elastomer for cartilage tissue engineering. J Biomed Mater Res A 2006; 77(2): 331-39.
41. Kuo YC, Lin CY. Effect of genipin-crosslinked chitin-chitosan scaffolds with hydroxyapatite modifications on the cultivation of bovine knee chondrocytes. Biotechnol Bioeng 2006; 95(1): 132-44.
42. Hofmann S, Knecht S, Langer R, et al. Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng 2006; 12(10): 2729-38.
43. Meinel L, Hofmann S, Karageorgiou V, et al. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng 2004; 88(3): 379-91.
44. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005; 11(1-2): 1-18.
45. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23(1): 47-55.
46. Van Hest JC, Tirrell DA. Protein-based materials, toward a new level of structural control. Chem Commun (Camb) 2001; 19: 1897-1904.
47. Kopecek J. Smart and genetically engineered biomaterials and drug delivery systems. Eur J Pharm Sci 2003; 20(1): 1-16.
48. Holland TA, Tessmar JK, Tabata Y, Mikos AG. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 2004; 94(1): 101-14.
49. DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006; 27(8): 1579-85.
50. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005; 26(34): 7095-7103.
51. Olney RC, Wang J, Sylvester JE, Mougey EB. Growth factor regulation of human growth plate chondrocyte proliferation in vitro. Biochem Biophys Res Commun 2004; 317(4): 1171-82.
52. Isogai N, Morotomi T, Hayakawa S, et al. Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth factor for tissue engineering an auricular cartilage construct. J Biomed Mater Res A 2005; 74(3): 408-18.
53. Louwerse RT, Heyligers IC, Klein-Nulend J, et al. Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats. J Biomed Mater Res 2000; 49(4): 506-16.
54. Kaps C, Bramlage C, Smolian H, et al. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002; 46(1): 149-62.
55. Fortier LA, Mohammed HO, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 2002; 84(2): 276-88.
56. Moioli EK, Mao JJ. Chondrogenesis of mesenchymal stem cells by controlled delivery of transforming growth factor-beta3. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 2647-50.
57. Yang XB, Whitaker MJ, Sebald W, et al. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 2004; 10(7-8): 1037-45.
58. Holland TA, Bodde EW, Cuijpers VM, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 2007; 15(2): 187-97.
59. Ando W, Tateishi K, Hart DA, et al. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 2007; 28(36): 5462-70.
60. Bryant SJ, Anseth KS. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 2002; 59(1): 63-72.
61. El-Amin SF, Kofron MD, Attawia MA, Lu HH, Tuan RS, Laurencin CT. Molecular regulation of osteoblasts for tissue engineered bone repair. Clin Orthop Relat Res 2004; (427): 220-25.
62. Jeschke B, Meyer J, Jonczyk A, et al. RGD-peptides for tissue engineering of articular cartilage. Biomaterials 2002; 23(16): 3455-63.
63. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999; 15(1): 19-32.
64. Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell JA. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 2002; 3(4): 710-23.
65. Raghunath J, Salacinski HJ, Sales KM, Butler PE, Seifalian AM. Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol 2005; 16(5): 503-09.
66. Tuzlakoglu K, Bolgen N, Salgado AJ, Gomes ME, Piskin E, Reis RL. Nano- and micro-fiber combined scaffolds: a new architecture for bone tissue engineering. J Mater Sci Mater Med 2005; 16(12): 1099-104.
67. Li WJ, Tuli R, Okafor C, et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005; 26(6): 599-609.
68. Connelly JT, Garcia AJ, Levenston ME. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. Biomaterials 2007; 28(6): 1071-83.
69. Noth U, Rackwitz L, Heymer A, et al. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J Biomed Mater Res A 2007; 83(3): 626-35.
70. Wang DA, Varghese S, Sharma B, et al. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater 2007; 6(5): 385-92.
71. Eyrich D, Brandl F, Appel B, et al. Long-term stable fibrin gels for cartilage engineering. Biomaterials 2007; 28(1): 55-65.
72. Silverman RP, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ. Injectable tissue-engineered cartilage using a fibrin glue polymer. Plast Reconstr Surg 1999; 103(7): 1809-18.
73. Lee CR, Grad S, Gorna K, Gogolewski S, Goessl A, Alini M. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng 2005; 11(9-10): 1562-73.